Onconova Therapeutics shares tumble 12%

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 21st, 2017

Why Did Cara Therapeutics Shares Tumble 13.6% in April?

Investors sold off shares in the pain-drug developer following a stock offering, and ahead of first-quarter earnings......»»

Category: topSource: foxnewsMay 6th, 2017

The Latest Buzz in Biotech

Shares in Juno Therapeutics and Amicus Therapeutics tumble on disappointing news, and one important drug at Pfizer takes a big step forward......»»

Category: topSource: foxnewsDec 6th, 2016

Mid-Day Market Update: U.S. Stocks Turn Higher; Nivalis Therapeutics Shares Tumble After Failed Drug Trial

  Midway through trading Tuesday, the Dow traded up 0.15 percent to 19,126.46 while the NASDAQ climbed 0.62 percent to 5,401.98. The S&P also rose, gaining 0.32 percent to 2,208.67. Leading and Lagging Sectors On Tuesday, healthcare shares gai.....»»

Category: earningsSource: benzingaNov 29th, 2016

How Big of a Deal Is Celgene"s Flop?

A disappointing late-stage trial failure is causing shares to tumble, but there's a lot going on at this company that could pan out for investors......»»

Category: topSource: foxnewsOct 20th, 2017

Shares of United Airlines tumble after 3Q financial report

Analysts for evidence that adding more flights and slashing prices to match budget carriers are boosting the company’s financial.....»»

Category: topSource: usatodayOct 19th, 2017

United Airlines shares tumble as 4Q guidance underwhelms

United Airlines shares fell sharply on Thursday, losing as much as 11.5 percent in midday trading as investors sold the carrier's shares after it released disappointing forecasts for the fourth quarter......»»

Category: topSource: foxnewsOct 19th, 2017

Hong Kong stocks suffer biggest fall in 2 months as property shares tumble

Late afternoon sell-off partly triggered by warnings over debt; property shares slump amid signs of sales slowdown in China.....»»

Category: topSource: business-standardOct 19th, 2017

ZTE Shares Tumble on 3Q Results, Buy on Dip?

Shares in ZTE.....»»

Category: futuresSource: nasdaqOct 19th, 2017

Capricor Therapeutics: 12-Month Data Could Push Shares Higher

Capricor Therapeutics: 12-Month Data Could Push Shares Higher.....»»

Category: topSource: seekingalphaOct 18th, 2017

Australia"s Crown hit by accusations of poker machine-fixing, shares tumble

SYDNEY (Reuters) - Australia's Crown Resorts Ltd was hit by allegations of tampering with poker machines on Wednesday when a lawmaker tabled a video of whistleblowers in parliament, sending shares in the casino firm sliding......»»

Category: topSource: reutersOct 18th, 2017

Amicus Therapeutics Inc (FOLD) Chairman & CEO John F Crowley Sold $6.4 million of Shares

Related Stocks: FOLD,.....»»

Category: personnelSource: nytOct 16th, 2017

Mid-Day Market Update: TransEnterix Climbs Following FDA Clearance Of Senhance Surgical Robot; TG Therapeutics Shares Decline

Midway through trading Monday, the Dow traded up 0.11 percent to 22,895.94 while the NASDAQ climbed 0.23 percent to 6,620.70. The S&P also rose, gaining 0.06 percent to 2,554.69. read more.....»»

Category: blogSource: benzingaOct 16th, 2017

The BLUE And The BOLD; Analyst Suggests Pair Trade Ahead Of Year-End Catalysts

Evercore ISI on Monday outlined a pair trade in the biotech sector, with the firm upgrading shares of bluebird bio Inc (NASDAQ: BLUE), while simultaneously downgrading those of Audentes Therapeutics Inc (NASDAQ: BOLD). Latest Ratings for BLUE.....»»

Category: blogSource: benzingaOct 16th, 2017

Kobe Steel shares tumble to near five-year low as cheating crisis deepens

TOKYO (Reuters) - Shares of embattled Kobe Steel Ltd tumbled to their lowest level in nearly 5 years on Monday, as a cheating scandal at the Japanese steelmaker ensnared hundreds of firms and left investors fearing for the financial and legal fallout......»»

Category: topSource: reutersOct 15th, 2017

Is Spark Therapeutics’ Luxturna a Game Changer?

Shares of Spark Therapeutics saw a handy gain to close out the week after the FDA recommended approval of Luxturna......»»

Category: blogSource: 247wallstOct 13th, 2017

Spark: A Big Win for Gene Therapy. So Why Is It Falling?

Shares of Spark Therapeutics are down today, despite winning the recommendation of a FDA advisory panel for its experimental gene therapy......»»

Category: blogSource: barronsOct 13th, 2017

Spark Therapeutics shares jump 7.5% after FDA committee backs blindness treatment

Shares of Spark Therapeutics Inc. surged 7.5% premarket Friday, after a U.S. Food and Drugs Administration advisory committee recommended approval of the company's gene therapy treatment for a rare eye disease that causes blindness. .....»»

Category: topSource: marketwatchOct 13th, 2017

Q3 Guidance Fell Down And Broke Its Crown, Now J.Jill Stock Is Tumbling After

J.Jill Inc (NYSE: JILL) shares took a tumble on Thursday after the women's apparel retailer preannou.....»»

Category: blogSource: benzingaOct 12th, 2017

J.C. Penney"s stock tumble toward another record low

Shares of J.C. Penney Co. Inc. tumbled 2.6% toward another record low in active trade Thursday, amid broad weakness in the retail sector after apparel retailer J.Jill Inc.'s profit warning. A.....»»

Category: topSource: marketwatchOct 12th, 2017

Spark Therapeutics shares halted as FDA committee reviews gene therapy treatment for eye disease

Spark Therapeutics Inc. shares were halted Thursday as a U.S. Food and Drugs Administration advisory committee meets to review the company's gene therapy treatment for patients with vision loss caused.....»»

Category: topSource: marketwatchOct 12th, 2017